 | Up a level |
Journal Article
Cappuzzo, Federico, Moro-Sibilot, Denis, Gautschi, Oliver, Boleti, Ekaterini, Felip, Enriqueta, Groen, Harry J. M., Germonpre, Paul, Meldgaard, Peter 
ORCID: 0000-0002-5788-4463, Arriola, Edurne ORCID: 0000-0001-8960-7519, Steele, Nicola, Fox, Jesme, Schnell, Patrick, Engelsberg, Arne and Wolf, Juergen
(2015).
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus.
Lung Cancer, 87 (2).
S. 89 - 96.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1872-8332
Solomon, Benjamin J., Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jurgen, Elamin, Yasir, Davis, Hannah M., Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K., Loong, Herbert H., Novello, Silvia, Arriola, Edurne, Perol, Maurice, Goto, Koichi and Santini, Fernando C. . Phase III study of selpercatinib vs chemotherapy plus /- pembrolizumab in untreated RET positive non-small-cell lung cancer. Future Oncol.. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301